ImageneBio, Inc. Ttl Fee Amt
ImageneBio, Inc. (IMA) had Ttl Fee Amt of $4.44 thousand as of 2026-08-04, per its S-3 filed 2026-08-05.
Financial Statements › Notes
ffd:TtlFeeAmt · last filed 2026-08-05
- 2026-08-04: Ttl Fee Amt $4.44K.
| Period end | Ttl Fee Amt |
|---|---|
| 2026-08-04 | $4.44K S-3 · filed 2026-08-05 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Inmune Bio, Inc. (INMB) | United States | $0.056B | -2.48 |
| BioAtla, Inc. (BCAB) | United States | $0.058B | -0.21 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Tevogen Inc. (TVGN) | United States | $0.049B | |
| Instil Bio, Inc. (TIL) | United States | $0.048B | -1.73 |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| LeonaBio, Inc. (LONA) | United States | $0.047B | -0.61 |
| Metagenomi Therapeutics, Inc. (MGX) | United States | $0.044B | -0.48 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B |